Biobanking of Specimens from COVID-19 Patients: An Economic Perspective from a Clinical Biobank

Biopreserv Biobank. 2021 Oct;19(5):453-456. doi: 10.1089/bio.2020.0168. Epub 2021 May 19.

Authors

Tanja Niedermair^{1

2}, Meet Bhatt³, Stefan Wallner⁴, Maximilian Babel^{1

2}, Ralph Burkhardt⁴, Christoph Brochhausen^{1

2}

Affiliations

¹ Institute of Pathology, University Regensburg, Regensburg, Germany.
² Central Biobank Regensburg, University and University Hospital Regensburg, Regensburg, Germany.
³ Biobank Cote d'Azur, Centre Hospitalier Universitaire de Nice, University Cote D'Azur, Nice, France.
⁴ Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany.

PMID: 34042517
DOI: 10.1089/bio.2020.0168

No abstract available

MeSH terms

Biological Specimen Banks
Biomedical Research*
COVID-19*
Humans
SARS-CoV-2